Medicinal Chemistry & Drug Discovery - International Journal of Phytotherapuetics & Bioactive Natural Products
General Overview of Manuscript
Manuscript must be written in English. Grammatical mistakes should be rectified before initial submission. All manuscripts must have a title, be double-line spaced with type no smaller than 12 point. Tables must be on separate pages after the reference list, and not be incorporated into the main text. Figures should be uploaded as separate Image files as well as embedded in the main document (word document) after the reference list and tables.
1. Manuscript Title
title page must list the full title (up to 80 characters) and names and affiliations of all authors. Full address, including email, telephone and fax, of the corresponding author must be provided.
All manuscripts must have a concise summary of the whole paper, not just the conclusions, and is understandable without reference to the rest of the paper. Main significant finding should be clearly discussed without citations. Maximum limit for abstract is 140 words. Each manuscript must include upto 6 keywords for classification and indexing purpose.
A concise and comprehensive introduction is required as background to justify the subject, its significance. Introduction must correlate the research work to be reported with the previous literature and work with proper references. Unnecessary details should be avoided such as background regarding general importance of natural products based drug discovery.
4. Material and Methods
Every manuscript should mention all important data regarding material and methods that could enable other scientist to reproduce the same work. All aspects of medicinal plants must be clearly mentioned i.e. Latin binomial for the plant, author of the name, plant family, source (e.g. country and region of collection, name of the collector and collection number) means of unambiguous identification (e.g. name and affiliation of expert botanist or the results of comparison with a published monograph and/or authenticated reference specimen). The reference number and place of deposition of a voucher specimen of the plant material must be given.
The section related to in-vitro or in-vivo pharmacological assays of plant extracts or isolated compounds must be accompanied by data for positive and negative controls. All studies associated with animal experiments must be conducted in accordance to either UK Animals (Scientific Procedures) Act 1986 and associated guidelines, the EEC Directive of 1986 (86/609/EEC) or the NIH guide for the care and use of laboratory animals (NIH Publication No. 80-23; revised 1978). Such research articles will be rejected if there is any uncertainty regarding use of inappropriate procedures. All chemicals used must be mentioned based on Chemical Abstracts nomenclature. Abbreviations should be explained when first mentioned. The nomenclature used to identify receptors and ion channels should conform to guidelines of the Committee on Receptor. Nomenclature and Drug Classification of the International Union of Basic and Clinical Pharmacology (NC-IUPHAR).
Results should be described separately. Results must be discussed comprehensively and unnecessary discussions should be avoided. Significance of data must be showed by using suitable and standard statistical methods.
Results should be explained concisely with reference to scientific literature. Conclusion of the article should be summarized at the end of discussion part. Conclusion should not exceed the limit of one paragraph.
Acknowledgements as well as funding resources may be stated at the end of articles.
All references mentioned in main body of manuscript must be present in the reference list. All the references should be complete in all respects. Unpublished work or journals in press should be cited using DOI systems. Citations in text may be mentioned directly e.g. Richard et al. (2009), or given in parenthetically such as “our previous data (Richard et al., 2009). Groups of references should be listed first alphabetically, then chronologically e.g. “activities have been reported (Albert et al., 2001; Chan., 2001, 2002a, 2002b; Richard et al., 2009).” All references should be arranged alphabetically and then further sorted chronologically if necessary. More than one reference from the same author(s) in the same year must be identified by the letters "a", "b", "c", etc., placed after the year of publication. Full names of journals should be used instead of using abbreviated names.
Kuroyanagi M, Arakawa T, Hirayama Y, Hayashi T. (1999). Antibacterial and antiandrogen flavonoids from Sophora flavescens. Journal of Natural Products 62, 1595-1599.
Rang H, Dale M, Ritter J, Flower R. (2007). Rang & Dale's Pharmacology. 6th ed. Churchill Livingstone, England, pp 23-27.
Chapter in an edited book:
Colbert CM. (2006). Preparation of Cortical Brain Slices for Electrophysiological Recording, in: Stockand, J.D., Shapiro, M.S. (Eds.), Ion channels: methods and protocols. Humana Press Inc., New Jersey, pp. 118-121.
Medicinal Chemistry & Drug Discovery receive submitted manuscripts from corresponding author through e-mail attachment to Editorial Office at firstname.lastname@example.org. Manuscripts must be submitted by one of the authors of submitted manuscript, and should not be submitted by anyone on their behalf. Corresponding author will be required to submit a Covering Letter along with the manuscript, on behalf of all the co-authors (if any).
Manuscript must be submitted in doc or Rtf (using MS word 2003 or any other proprietary software) format. MS word 2007 or later docx formats are not acceptable. All figures must be provided in JPEG or PDF formats with minimum resolution 300 dpi (for colored figures) and 600 dpi (for line art or drawing). Chemical structures prepared in ChemDraw software will be accepted in .doc- or .rtf-embedded form. Finally a single .zip file (compressed file) must be provided comprising all individual files.
Authors will also submit the names and contact details of at least three proposed reviewers. Submission of a manuscript will be held to imply that it contains original unpublished work and is not being submitted for publication elsewhere at the same time. The author(s) must assure that the neither the manuscript (its part) has been published previously nor it is under consideration for publication anywhere. Moreover, any figure, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be properly obtained.
Corresponding author is responsible for final check list and must ensure the presence of Email address, Full postal address, Telephone and fax numbers, complete manuscript with embedded figures and tables, Keywords, All figure captions, All tables (including title, description, footnotes) in a zip (.zip format) folder. Other aspects include the surety that each manuscript has been "spellchecked" and "grammar-checked", references are in the correct format for this journal and all references mentioned in the Reference list are cited in the text, and vice versa. Finally, Permission letter(s) regarding use of copyrighted material from other sources (including the Web) must be checked.
Peer Review Policy
Submitted manuscripts are handled by editorial office, which are subjected to initial revision by Editor and/or Editorial board. After preliminary qualification, manuscript is thoroughly and rapidly reviewed by expert anonymized reviewers.
Inforesights Publishing strictly follows ethical guidelines to avoid malpractice, which are mentioned below:
1. Conflict of interest
All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work.
2. Declaration of submission
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere including electronically in the same form, in English or in any other language, without the written consent of the copyright-holder.
3. Funding source
All authors are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.
Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered.
After article acceptance
1. Publication Charges
Currently articles are published without any article processing charges (APCs).
2. Copyright Issues
By submitting a manuscript, the authors agree that the copyrights of their article are transferred to the publishers if and when the article is accepted for publication. If the manuscript contains details including figures from other copyright works it will be the sole author's responsibility to get written permission from the owners of the publishing rights to reproduce such material using the Inforesights Publishing Permission Request Form.
After acceptance page proofs (as a pdf file) will be sent to corresponding author through email. At this stage, only those errors can be corrected that may have been introduced during the production process. After publishing, corresponding author will be provided with a PDF file of the article at no cost via e-mail.